Bliss GVS Pharma Limited

NSEI:BLISSGVS 주식 보고서

시가총액: ₹10.6b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Bliss GVS Pharma 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Gagan Sharma

최고 경영자

₹18.0m

총 보상

CEO 급여 비율100.0%
CEO 임기3.1yrs
CEO 소유권n/a
경영진 평균 재임 기간3.1yrs
이사회 평균 재임 기간10.5yrs

최근 관리 업데이트

Recent updates

We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

May 10
We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Apr 27
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Jan 26
There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Jul 14
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Sep 11
Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Aug 28
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

May 21
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

Apr 08
Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Mar 18
A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Feb 25
Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

Feb 08
Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Jan 21
What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

Jan 08
Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Dec 26
How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Dec 13
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Nov 30
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Nov 18
Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Nov 06
Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Oct 25
Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Oct 07
Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Sep 19
How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?

Sep 04
What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?

Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?

Aug 17
Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?

The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More

Aug 04
The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More

Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)

Aug 04
Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly

Jul 21
Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Jul 06
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

CEO 보상 분석

Gagan Sharma 의 보수는 Bliss GVS Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

₹755m

Dec 31 2023n/an/a

₹879m

Sep 30 2023n/an/a

₹883m

Jun 30 2023n/an/a

₹598m

Mar 31 2023₹18m₹18m

₹709m

Dec 31 2022n/an/a

₹871m

Sep 30 2022n/an/a

₹91m

Jun 30 2022n/an/a

₹165m

Mar 31 2022₹15m₹15m

₹150m

Dec 31 2021n/an/a

₹17m

Sep 30 2021n/an/a

₹773m

Jun 30 2021n/an/a

₹766m

Mar 31 2021₹1m₹1m

₹685m

보상 대 시장: Gagan 의 총 보상 ($USD 216.07K )은 Indian 시장( $USD 38.49K ).

보상과 수익: Gagan 의 보상은 지난 1년 동안 20% 이상 증가했습니다.


CEO

Gagan Sharma (41 yo)

3.1yrs

테뉴어

₹18,032,817

보상

Mr. Gagan Harsh Sharma serves as Managing Director at Bliss GVS Pharma Limited since May 11, 2021 and its Director since January 21, 2021. He served as Vice President of Strategy and Business Development a...


리더십 팀

이름위치테뉴어보상소유권
Gagan Sharma
MD & Director3.1yrs₹18.03m데이터 없음
Deepak Sawant
Chief Financial Officer1.5yrs₹1.63m데이터 없음
Aditi Bhatt
Compliance Officer5.8yrs₹1.55m데이터 없음
Vibha Sharma
Executive & Whole Time Directorno data₹7.05m2.36%
₹ 250.7m
Shruti Vishal Rao
Executive & Whole Time Directorno data₹6.73m2.01%
₹ 213.7m

3.1yrs

평균 재임 기간

41yo

평균 연령

경험이 풍부한 관리: BLISSGVS 의 관리팀은 경험 ( 3.1 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Gagan Sharma
MD & Director3.4yrs₹18.03m데이터 없음
Vibha Sharma
Executive & Whole Time Director15.9yrs₹7.05m2.36%
₹ 250.7m
Shruti Vishal Rao
Executive & Whole Time Director17.9yrs₹6.73m2.01%
₹ 213.7m
Subramanian Vaidya
Independent Chairman of the Board12.9yrs₹375.00k데이터 없음
Shilpa Bhatia
Independent Women Director4.3yrs₹375.00k데이터 없음
Santosh Parab
Independent Non-Executive Director8.1yrs₹375.00k0.0022%
₹ 233.4k

10.5yrs

평균 재임 기간

45.5yo

평균 연령

경험이 풍부한 이사회: BLISSGVS 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10.5 년).